Please upgrade your browser to view this website properly.

EyeIC's MatchedFlicker is a groundbreaking new technology for monitoring the advent and progression of retinal disease and glaucoma through change detection in time series images.

About EyeIC

EyeIC is a cutting-edge medical technology firm dedicated to commercializing imaging technologies for medical applications.

EyeIC was founded around patented technology developed by Dr. Jeffrey Berger and colleagues at the University of Pennsylvania's School of Medicine who were interested in the application of information technology to medical imaging. While the initial uses are in ophthalmology, MatchedFlicker has broader applications throughout medicine.


  • Philip Heifetz – President and CEO

    Mr. Heifetz has 15 years of experience in senior management of life science and health technology companies. Prior to EyeIC, he was head of finance and business development for two different biotechnology companies (Othera Pharmaceuticals and Plantgenix). He has either directly raised or been instrumental in bringing in over $50 million in investment, and led the sale of a clinical-stage development program for $7.5 million. In addition to a BS in Chemistry from Georgetown University, he earned an MBA from the Wharton School of the University of Pennsylvania with a dual concentration in health care management and entrepreneurship.

  • Alan Golombek – EyePACS Business Development

    Mr. Golombek has more than 35 years of experience in the hospital sector, including positions where he has worked with the corporate level within many of the largest integrated health care networks and group purchasing organizations in the United States and Canada. For the last 25 years he has held various management positions with medical companies focusing in the area of critical care, cardiac disease, and physiological monitoring. He has been recognized for his expertise in the management and development of sales personnel, and has participated in key marketing and product development programs at all levels of the corporation. Mr. Golombek is a graduate of Temple University in Philadelphia

  • Steve Bakanov, MS, Ph.D. – Technology Director

    Dr. Bakanov is a successful IT leader with over 20 years experience. He has developed innovative IT solutions for industry-leading global and domestic companies and was responsible for solutions system-wide design and implementations in more than 200 healthcare organizations, supporting more than 100 million global users. He has provided consulting and system implementation services to numerous manufacturing and healthcare companies including Blue Cross/Blue Shield, CareFirst, USA Mutual Life Insurance, ABB and IBM. He has experience in programming across a variety of languages and technologies, and has led development teams in a variety of projects. Steve is a member of multiple CIO advisory boards and Senior Technology Executives organizations.


  • Launch Capital
  • MentorTech Ventures
  • Ben Franklin Technology Partners
  • Keiretsu Forum

Currently, EyeIC is accepting inquiries from qualified investors who are interested in growing a technology brand backed by rigorous scientific research. Please contact us if you'd like to schedule an appointment with one of our representatives to discuss this unique opportunity.